← FDA Drug Approvals (Drugs@FDA)

DAPTOMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2024-08-01

Drug application

FDA Application #

ANDA213396

Application type

Abbreviated New Drug Application (Generic)

Brand name

DAPTOMYCIN

Generic name

Daptomycin

Active ingredients

DAPTOMYCIN

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

FRESENIUS KABI USA

First approval

2024-08-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown